GENTAUR U.S.A Genprice Inc 6017 Snell Ave, Ste 357, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, email@example.com
Index / FabGennix / Human Lactoferrin, Host species: Rabbit, Polyclonal antibody / Product Detail : Hlac-101AP Human Lactoferrin, Host species: Rabbit, Polyclonal antibody
#Hlac-101AP Human Lactoferrin, Host species: Rabbit, Polyclonal antibody
Product name : Human Lactoferrin, Host species: Rabbit, Polyclonal antibody
Catalog number : Hlac-101AP
Supplier name : FabGennix
Data sheet: Ask more or other datasheet now !
About this Product :Human Lactoferrin, Host species: Rabbit, Polyclonal antibody antibody storage GENTAUR recommends for long therm storage to freeze at -24 C. For short time storage up to 30 days we suggest fridge storage at 1 to 10 C. Prevent multiple freeze taw cycles of Human Lactoferrin, Host species: Rabbit, Polyclonal antibody .
Human Lactoferrin, Host species: Rabbit, Polyclonal antibody rabbit polyclonal These antibodies are very stable and can be stored up to 2 months at fridge temperature under 10C. Do not freeze taw, rather use Human Lactoferrin, Host species: Rabbit, Polyclonal antibody from the fridge if your use is less than 1 or 2 weeks.
More Details about
Lactoferrin, an iron-binding glycoprotein with an approximate molecular weight of 80 kDa. The protein has two iron binding domains each housing one Fe(3+) and the synergistic CO(3)(2-) ion (1). The crystal structure of differic form of human lactoferrin at 2.2A resolution exhibit 5330 protein atoms, 2Fe+2 , 2CO3-2 and 98 carbohydrate atoms (1).
Lactoferrin is absorbed from intestine by apical; side of the membrane and localized to the nuclei (2). Anti-lactoferrin antibodies were detected in some patients with rheumatoid arthritis and systemic lupus erythematousus and other muscle diseases (3). Intravenous infusion of lactoferrin is also protective against lethal dose of E coli induce bacterimia by a mechanism that down regulate neutrophil TNF alfa secretion (4). Recombinant human lactoferrin (rhLF), expressed and extracted from rice seed, is being evaluated for use as a dietary supplement to treat iron deficiency and/or iron deficiency-induced anemia. Lactoferrin has been shown to have a role in immune system and in early development of embryo. A specific receptor for lactoferrin binding has been implicated in human fetal intestine (5). Early embryonic localization of lactiferrin by IHC has suggested its presence in various tissues including intestinal epitheliuem, kiney, and various regions of the brain.
FabGennix International Inc. has produced affinity purified antibdies to human and bovine lactoferrin proteins. These antibodies are generated in rabbit using purified human or bovine lactoferrin proteins. The lactoferrin antibodies were then affinity purufied using immobilized antigenic proteins and pre-adsorbed on an immobilized heterologus lactoferin matrix to remove the cross-reacting antibodies. Limited quantities of blocking protein is also available (please inquire). FabGennix, Inc., will also provide Western blot positive controls for most of these antibodies in ready-to-use buffer for easy identification of respective proteins.
For research use only, not for diagnostic or therapeutic use.
Contact us about this product :
Our team will respond you as soon as possible !
52062 Aachen Deutschland
Support Karolina Elandt
Fax: (+49) 241 56 00 47 88
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
firstname.lastname@example.org | Gentaur
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Finland Helsset +358942419041
Magyarország Budapest +3619980547
US New York+17185132983
WP2107: pathways in human cancer
Related Genes :
[TP53 P53] Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53)
[ELANE ELA2] Neutrophil elastase (EC 126.96.36.199) (Bone marrow serine protease) (Elastase-2) (Human leukocyte elastase) (HLE) (Medullasin) (PMN elastase)
[AR DHTR NR3C4] Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4)
[RACK1 GNB2L1 HLC7 PIG21] Receptor of activated protein C kinase 1 (Cell proliferation-inducing gene 21 protein) (Guanine nucleotide-binding protein subunit beta-2-like 1) (Guanine nucleotide-binding protein subunit beta-like protein 12.3) (Human lung cancer oncogene 7 protein) (HLC-7) (Receptor for activated C kinase) [Cleaved into: Receptor of activated protein C kinase 1, N-terminally processed (Guanine nucleotide-binding protein subunit beta-2-like 1, N-terminally processed)]
[SCN5A] Sodium channel protein type 5 subunit alpha (HH1) (Sodium channel protein cardiac muscle subunit alpha) (Sodium channel protein type V subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.5)
[EGFR ERBB ERBB1 HER1] Epidermal growth factor receptor (EC 188.8.131.52) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1)
[CTNNB1 CTNNB OK/SW-cl.35 PRO2286] Catenin beta-1 (Beta-catenin)
[FBN1 FBN] Fibrillin-1 [Cleaved into: Asprosin]
[F8 F8C] Coagulation factor VIII (Antihemophilic factor) (AHF) (Procoagulant component) [Cleaved into: Factor VIIIa heavy chain, 200 kDa isoform; Factor VIIIa heavy chain, 92 kDa isoform; Factor VIII B chain; Factor VIIIa light chain]
[BRCA1 RNF53] Breast cancer type 1 susceptibility protein (EC 6.3.2.-) (RING finger protein 53)
[HBB] Hemoglobin subunit beta (Beta-globin) (Hemoglobin beta chain) [Cleaved into: LVV-hemorphin-7; Spinorphin]
[CCNDBP1 DIP1 GCIP HHM] Cyclin-D1-binding protein 1 (Grap2 and cyclin-D-interacting protein) (Human homolog of Maid)
[gag-pol] Gag-Pol polyprotein (Pr160Gag-Pol) [Cleaved into: Matrix protein p17 (MA); Capsid protein p24 (CA); Spacer peptide 1 (SP1) (p2); Nucleocapsid protein p7 (NC); Transframe peptide (TF); p6-pol (p6*); Protease (EC 184.108.40.206) (PR) (Retropepsin); Reverse transcriptase/ribonuclease H (EC 220.127.116.11) (EC 18.104.22.168) (EC 22.214.171.124) (Exoribonuclease H) (EC 126.96.36.199) (p66 RT); p51 RT; p15; Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]
[SIRT1 SIR2L1] NAD-dependent protein deacetylase sirtuin-1 (hSIRT1) (EC 3.5.1.-) (Regulatory protein SIR2 homolog 1) (SIR2-like protein 1) (hSIR2) [Cleaved into: SirtT1 75 kDa fragment (75SirT1)]
[AKAP13 BRX HT31 LBC] A-kinase anchor protein 13 (AKAP-13) (AKAP-Lbc) (Breast cancer nuclear receptor-binding auxiliary protein) (Guanine nucleotide exchange factor Lbc) (Human thyroid-anchoring protein 31) (Lymphoid blast crisis oncogene) (LBC oncogene) (Non-oncogenic Rho GTPase-specific GTP exchange factor) (Protein kinase A-anchoring protein 13) (PRKA13) (p47)
[APP A4 AD1] Amyloid beta A4 protein (ABPP) (APPI) (APP) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Beta-amyloid precursor protein) (Cerebral vascular amyloid peptide) (CVAP) (PreA4) (Protease nexin-II) (PN-II) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99; Beta-amyloid protein 42 (Beta-APP42); Beta-amyloid protein 40 (Beta-APP40); C83; P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Amyloid intracellular domain 59) (AICD-59) (AID(59)) (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Amyloid intracellular domain 57) (AICD-57) (AID(57)) (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Amyloid intracellular domain 50) (AICD-50) (AID(50)) (Gamma-CTF(50)); C31]
[LRRK2 PARK8] Leucine-rich repeat serine/threonine-protein kinase 2 (EC 188.8.131.52) (Dardarin)
[UBE3A E6AP EPVE6AP HPVE6A] Ubiquitin-protein ligase E3A (EC 6.3.2.-) (E6AP ubiquitin-protein ligase) (Human papillomavirus E6-associated protein) (Oncogenic protein-associated protein E6-AP) (Renal carcinoma antigen NY-REN-54)
[GOLGA2] Golgin subfamily A member 2 (130 kDa cis-Golgi matrix protein) (GM130) (GM130 autoantigen) (Golgin-95)
[AKT1 PKB RAC] RAC-alpha serine/threonine-protein kinase (EC 184.108.40.206) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)
[INSR] Insulin receptor (IR) (EC 220.127.116.11) (CD antigen CD220) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta]
[TGFB1 TGFB] Transforming growth factor beta-1 (TGF-beta-1) [Cleaved into: Latency-associated peptide (LAP)]
[SCN1A NAC1 SCN1] Sodium channel protein type 1 subunit alpha (Sodium channel protein brain I subunit alpha) (Sodium channel protein type I subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.1)
[TTN] Titin (EC 18.104.22.168) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14)
[SRC SRC1] Proto-oncogene tyrosine-protein kinase Src (EC 22.214.171.124) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)
[KIT SCFR] Mast/stem cell growth factor receptor Kit (SCFR) (EC 126.96.36.199) (Piebald trait protein) (PBT) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (p145 c-kit) (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (CD antigen CD117)
[FGFR2 BEK KGFR KSAM] Fibroblast growth factor receptor 2 (FGFR-2) (EC 188.8.131.52) (K-sam) (KGFR) (Keratinocyte growth factor receptor) (CD antigen CD332)
[EPHA3 ETK ETK1 HEK TYRO4] Ephrin type-A receptor 3 (EC 184.108.40.206) (EPH-like kinase 4) (EK4) (hEK4) (HEK) (Human embryo kinase) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) (Eph-like tyrosine kinase 1)
[KCNQ1 KCNA8 KCNA9 KVLQT1] Potassium voltage-gated channel subfamily KQT member 1 (IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1) (KQT-like 1) (Voltage-gated potassium channel subunit Kv7.1)
[APOE] Apolipoprotein E (Apo-E)
 A Functional and Clinical Reinterpretation of Human Perineal Neuromuscular Anatomy.
 Barriers to Mental Health Care for an Ethnically and Racially Diverse Sample of Older Adults.
 Photoinduced mild hyperthermia and synergistic chemotherapy by one-pot synthesized docetaxel-loaded PLGA/Polypyrrole Nanocomposites.
 On Expression Patterns and Developmental Origin of Human Brain Regions.
 Open-Air Biowarfare Testing and the Evolution of Values.
 Clinical Contributions to the Available Sources of Evidence (CASE) Reports: Executive Summary (a).
 Beta Testing a Novel Smartphone Application to Improve Medication Adherence.
 5-HT2A/5-HT2C receptor pharmacology and intrinsic clearance of N-benzylphenethylamines modified at the primary site of metabolism.
 Modulation of physiological mirror activity with transcranial direct current stimulation over dorsal premotor cortex.
 A Coarse-Grained Model of Stratum Corneum Lipids: Free Fatty Acids and Ceramide NS.
Enter catalog number :